0|chunk|The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule
0	4	13 Disulfide	Chemical	CHEBI_48343
0	23	35 Glycoprotein	Chemical	CHEBI_17089
0	100	108 Molecule	Chemical	CHEBI_25367
0	CHEBI-CHEBI	CHEBI_48343	CHEBI_17089
0	CHEBI-CHEBI	CHEBI_48343	CHEBI_25367
0	CHEBI-CHEBI	CHEBI_17089	CHEBI_25367

1|chunk|Hepatitis C virus (HCV), a major cause of chronic liver disease in humans, is the focus of intense research efforts worldwide. Yet structural data on the viral envelope glycoproteins E1 and E2 are scarce, in spite of their essential role in the viral life cycle. To obtain more information, we developed an efficient production system of recombinant E2 ectodomain (E2e), truncated immediately upstream its trans-membrane (TM) region, using Drosophila melanogaster cells. This system yields a majority of monomeric protein, which can be readily separated chromatographically from contaminating disulfide-linked aggregates. The isolated monomeric E2e reacts with a number of conformation-sensitive monoclonal antibodies, binds the soluble CD81 large external loop and efficiently inhibits infection of Huh7.5 cells by infectious HCV particles (HCVcc) in a dose-dependent manner, suggesting that it adopts a native conformation. These properties of E2e led us to experimentally determine the connectivity of its 9 disulfide bonds, which are strictly conserved across HCV genotypes. Furthermore, circular dichroism combined with infrared spectroscopy analyses revealed the secondary structure contents of E2e, indicating in particular about 28% b-sheet, in agreement with the consensus secondary structure predictions. The disulfide connectivity pattern, together with data on the CD81 binding site and reported E2 deletion mutants, enabled the threading of the E2e polypeptide chain onto the structural template of class II fusion proteins of related flavi-and alphaviruses. The resulting model of the tertiary organization of E2 gives key information on the antigenicity determinants of the virus, maps the receptor binding site to the interface of domains I and III, and provides insight into the nature of a putative fusogenic conformational change.
1	169	182 glycoproteins	Chemical	CHEBI_17089
1	233	237 role	Chemical	CHEBI_50906
1	1011	1020 disulfide	Chemical	CHEBI_48343
1	1319	1328 disulfide	Chemical	CHEBI_48343
1	1462	1473 polypeptide	Chemical	CHEBI_15841
1	1462	1479 polypeptide chain	Chemical	CHEBI_16541
1	1528	1536 proteins	Chemical	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_17089	CHEBI_50906
1	CHEBI-CHEBI	CHEBI_17089	CHEBI_48343
1	CHEBI-CHEBI	CHEBI_17089	CHEBI_15841
1	CHEBI-CHEBI	CHEBI_17089	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_17089	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_48343
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_15841
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_50906	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_48343	CHEBI_15841
1	CHEBI-CHEBI	CHEBI_48343	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_48343	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_15841	CHEBI_16541
1	CHEBI-CHEBI	CHEBI_15841	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_16541	CHEBI_36080

